Berlin-based Levy unlocks €2.5 million to decode women’s fertility

With the aim of helping women who want to conceive, Berlin-based female-led startup LEVY Health has brought home €2.5 million. The round was led by Atlantic Labs and saw the participation of Austrian VC Calm Storm (heyvie, Keleya) and a number of angel investors, including women like Lea von Bidder (AVA), Jenny Saft (OVIAVO), Hansi Hansmann and Marie-Sophie von Bibra (Readly).

Founded by Theresa Vilsmaier, Silvia Hecher and Caroline Mitterdorfer, the platform is on a mission to help women who want to have children decode their fertility as quickly as possible. It has developed CE-compliant software to decipher women’s fertility. The LEVY Fertility Code is based on clinical guidelines from the EU and the U.S.

Analysing female fertility disorders, the software is currently available in Germany since the end of January and helps women and couples find out why they have not been able to get pregnant yet. Based on the results, users are given personalised therapy recommendations. LEVY Health looks at each woman, her body and her situation individually, bringing holistic reproductive medicine straight to users’ homes.

Caroline Mitterdorfer, co-founder and CEO, LEVY Health said: “We can now help women who want to have children both decode their fertility and show them how to boost their chances of conceiving with the LEVY Fertility Code.”

Christophe Maire, founding partner, Atlantic Labs added: “With medical precision diagnostics and individualised therapy plans, LEVY is revolutionizing the way infertility is dealt with, helping people conceive and become parents. We have been involved in the FemTech space for quite some time.”